menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
        • Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

        • Make trials easier to run, faster to launch, more engaging, and accessible to all.

        • Deliver reliable, scalable, and regulatory-ready eCOA for global Central Nervous System (CNS) trials.

        • Deploy early phase oncology trials in as little as 2 weeks with a cost-effective solution.

        • Accelerate your clinical trial setup with pre-validated and configured eCOA assessments.

        • Expert guidance for capturing high-quality, regulatory compliant data from the right participants at the right time.

        • Improve data accuracy and reduce variability in scoring with Clario's training solutions.

        • Accurately monitor for Suicidal Ideation and Behavior using Clario's exclusive self-reported eC-SSRS.

        • Clario is your trusted parter to ensure you get your clinical trial back on track.

        • Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

        • Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

        • Generate reliable pulmonary data with low variability and high patient compliance.

        • Support high-quality data, guided technique, and AI-enabled spirometry insights.

        • Centralized, on-site pulmonary function testing for clinical trials.

        • Remote spirometry testing for respiratory clinical trials.

        • Assess cough frequency, cough severity, and other lung sounds.

        • Assess the capacity of the lungs for effective gas transfer.

        • Capture daily symptoms and spirometry to demonstrate respiratory safety and efficacy.

        • Effortless, non-spirometry insight into lung health, including small airway function.

        • Monitor spirometry data quality and plausibility with expert clinical specialist validation.

        • Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
    • Study Phases
    • Technology
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values and Culture
  • Support
    • Customer Support
    • In-Country Customer Support
    • Contact
  • Solutions
    • Study Endpoints
      • Cardiac Solutions
        • Cardiac Solutions
        • Arrhythmia Analysis
        • Blood Pressure Services
        • ECG – On-site to DCT and Phase I-IV
        • Phase I/TQT Cardiac Assessment
        • Regulatory Consultation and Statistical Analysis Expertise
      • Clinical Adjudication
      • eCOA
        • eCOA Clinical Trials – Overview
        • eCOA Neuroscience
        • eCOA Swift – Early Phase
        • eCOA Rapid Start – Assessment Catalog
        • eCOA Science Services
        • Rater, Participant and Caregiver Training
        • Suicidal Ideation
        • eCOA Rescue Studies
        • eCOA Live
        • eCOA Multimedia
      • Medical Imaging
        • Medical Imaging
        • Image Redact AI
        • Imaging Platform
        • Medical Imaging Science Team
        • Modalities
        • SMART Submit
      • Precision Motion
        • Precision Motion for Clinical Trials
        • Precision Motion for Research
        • Precision Motion: Scientific Publications
      • Respiratory Solutions
        • Respiratory Solutions
        • Solutions for Healthcare Providers
        • Site-Based Spirometry
        • Virtual Home Spirometry
        • Cough and Lung Sounds
        • Diffusing Capacity (DLCO)
        • Spirometry and ePROs
        • Oscillometry
        • Scientific Spirometry Quality Review
      • Trial Enablement
        • Trial Enablement
        • Eligibility Solution
        • Reporting & Analytics
        • Source Document Manager
    • Segments
      • Biotechs
      • CROs
      • Pharma
    • Study Phases
      • Phase I
      • Phase II/III
    • Technology
      • Artificial Intelligence (AI)
      • Hybrid Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Diabetes and Obesity
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
      • Dementias
      • Headache Disorders
      • Movement Disorders
      • Multiple Sclerosis
      • Pain Disorders
      • Psychiatric Disorders
    • Oncology
    • Ophthalmology
    • Respiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values and Culture
  • Support
    • Customer Support
    • In-Country Customer Support
    • Contact
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Get started
    • Log in
    • Get started
  1. Home Resources Downloads An AI-based framework to identify duplicate ECGs in clinical trials

An AI-based framework to identify duplicate ECGs in clinical trials

How the ECG Mirror Participant tool helps sponsors detect anomalous ECG data, investigate potential duplicate recordings, and strengthen data integrity oversight across clinical trial sites.

Authors:

  • Alain Gay, M.D.
  • Jean-Philippe Couderc, MBA, Ph.D.
  • Luc Dekie, Ph.D.
  • Todd Rudo, M.D.
  • Vickas Patel, M.D., Ph.D.
  • Hui Zhao, Ph.D.

Summary

This white paper introduces an AI-based framework for identifying duplicate or mislabeled ECGs in clinical trials. By learning participant-specific electrophysiologic signatures and calculating dissimilarity scores across ECG recordings, the approach helps detect unexpectedly similar data between participants and surfaces potential data integrity risks for sponsor review. 

Why ECG data integrity matters 

Clinical trial sponsors rely on accurate ECG collection to evaluate drug safety, but conventional monitoring may not reveal every protocol deviation or anomalous recording pattern across geographically dispersed sites and large datasets. 

Mislabeled, duplicated, or fabricated ECGs can obscure true cardiac safety signals, distort efficacy and safety assessments, delay access to effective therapies, and increase regulatory and ethical risk. 

What is a “mirror participant”? 

A mirror participant refers to a single individual being enrolled as multiple study participants in a clinical trial, resulting in highly similar ECG morphologies appearing under different participant IDs.

How the ECG Mirror Participant framework works

The white paper maps the process into a practical review workflow that combines AI-generated similarity scoring with expert interpretation.

01

Learn participant-specific ECG signatures

The model analyzes 12-lead ECG morphology and learns stable, participant-specific patterns rather than relying on superficial visual similarity.

02

Calculate dissimilarity scores

ECG strips are compared within and across study participants. A low dissimilarity score indicates that two tracings are unexpectedly similar. This is true only when comparing ECGs across study participants. Within the same participant, a low dissimilarity score is expected.

03

Generate study-level heatmaps

Study-level maps summarize the minimum dissimilarity between participant pairs, making suspicious cross-participant similarity patterns easy to spot.

03

Drill into intra-participant maps

When suspicious data are found, intra-participant maps help reviewers isolate ECG strips that appear inconsistent with the rest of a participant’s longitudinal record.

Figure 1, Panel A: Study-level map showing minimum dissimilarity scores across participant pairs. Light cells indicate unexpectedly similar ECGs across different participant IDs.

Figure 1, Panel B: Intra-participant map used to identify ECG strips that appear inconsistent with the rest of a participant’s longitudinal record. Note: Dark cells indicate unexpectedly different ECGs from the same participant.

Why this matters for sponsors

Compliance Icon Reverse RGB

Strengthen oversight 
Review more ECG tracings than a manual process alone could realistically handle while maintaining consistency across large studies. 

Evidence Icon Reverse RGB

Increase data confidence 
Identify anomalous patterns earlier and build greater confidence in the evidence submitted to regulatory authorities. 

Insights Icon Reverse RGB

Prioritize expert review 
Use AI-generated outputs to focus cardiologist attention on the sites, participants, and ECG strips most likely to require investigation.

Explore the full white paper

Get the complete white paper or get started and continue the conversation. 

Download white paper
Get started

FAQs

How does the tool detect duplicate or mislabeled ECGs?

The framework calculates dissimilarity scores across ECG pairs, highlights suspicious cross-participant similarity at the study level, and then drills into participant-specific maps to locate inconsistent recordings. 

Does this replace cardiologist review?

No. The AI framework helps surface suspicious patterns efficiently, while cardiologists review flagged ECG tracing pairs and participant-level outputs to confirm whether further investigation is warranted. 

Can thresholds vary by study type?

Yes. The paper notes that thresholds may be adjusted for certain study types, including long-term follow-up studies where physiologic change within a participant may affect ECG morphology over time. 

Download
Back to downloads
Share
Twitter Facebook LinkedIn

Latest Downloads

See all
eBook

5 things to consider before starting your psychiatric clinical trial

Download icon Download icon
Download
White Paper

Phase-by-phase endpoint strategy guide for obesity and diabetes drug development

Download icon Download icon
Download
Poster

From Paper to Precision: Improved MADRS Scoring Accuracy with eCOA Implementation

Download icon Download icon
Download
Datasheet

Optimize trial design, data quality and regulatory strategy with Clario’s science experts

Download icon Download icon
Download
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Get started

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.

Step 1 of 2 - Quick and easy to complete

Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2026 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum